IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Actavis
Symbol: ACT
Price: Last trade $284.00
Trade Date: 2/27
Shares: 14.79 million
Underwriter(s) J.P. Morgan, Mizuho Securities, Wells Fargo Securities, Morgan Stanley, Barclays, Citigroup
Rating=Subscription Needed
Secondary’s Announced 2.19.2015
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish